Overview
- 4 inspections across 4 sites are on record.
- 2 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2019-08-02.
At a glance
Inspections
4
Sites
4
Observations
2
Career since
Feb 2017
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Novum Pharmaceutical Research Services Inc. | 2 Aug 2019 | Human Drugs | |
| Alturas Analytics, Inc. | 16 Feb 2018 | Human Drugs | On file |
| Diteba Inc | 4 Aug 2017 | Human Drugs | |
| Amgen, Inc. | 17 Feb 2017 | Human Drugs | On file |
Sites inspected
Novum Pharmaceutical Research Services Inc.Scarborough, Canada1 insp.
Alturas Analytics, Inc.Moscow, United States1 insp.
Diteba IncMississauga, Canada1 insp.
Amgen, Inc.Thousand Oaks, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Full investigator report
Get the verbatim findings behind Stanley Au's 2 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site